Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS(® )MPH: is treatment response different between children and adolescents?

BACKGROUND: To compare clinical and health-related quality of life (HRQoL) outcomes between children and adolescents with ADHD treated with OROS(® )MPH, using data from two large similarly-designed multicenter, prospective, open-label, single-arm, non-interventional studies. METHODS: Pooled analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Berek, Michael, Kordon, Andreas, Hargarter, Ludger, Mattejat, Fritz, Slawik, Lara, Rettig, Klaus, Schäuble, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162502/
https://www.ncbi.nlm.nih.gov/pubmed/21791096
http://dx.doi.org/10.1186/1753-2000-5-26

Ejemplares similares

Ejemplares similares